Literature DB >> 19691550

Founder effects for ATM gene mutations in Italian Ataxia Telangiectasia families.

Luciana Chessa1, Maria Piane, Monia Magliozzi, Isabella Torrente, Camilla Savio, Patrizia Lulli, Alessandro De Luca, Bruno Dallapiccola.   

Abstract

We screened ATM gene mutations in 104 Italian Ataxia-Telangiectasia patients from 91 unrelated families (detection rate 90%) and found 21 recurrent mutations in 63 families. The majority (67%) of patients were compound heterozygotes, while 33% were homozygotes. To determine the existence of common haplotypes and potential founder effects, we analyzed five microsatellite markers within and flanking the ATM gene. Haplotype analysis was carried out in 48/63 families harbouring 16 of the 21 recurrent mutations. Forty different haplotypes were detected in the 48 A-T families studied. We found that the majority of patients with the same recurrent mutation originated from the same geographical area. All but one recurrent mutation analyzed displayed a common haplotype suggesting a single origin that then spread to different geographical areas. The high number of different haplotypes does not allow the screening of ATM mutations by haplotype analysis alone in the Italian population. The finding of recurrent public mutations without founder effect suggests the existence of 'mild' hot spots of mutation located along the sequence of the ATM gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19691550     DOI: 10.1111/j.1469-1809.2009.00535.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  7 in total

1.  Molecular defects in Moroccan patients with ataxia-telangiectasia.

Authors:  L Jeddane; F Ailal; C Dubois-d'Enghien; O Abidi; I Benhsaien; A Kili; S Chaouki; Y Kriouile; N El Hafidi; H Fadil; R Abilkassem; N Rada; A A Bousfiha; A Barakat; D Stoppa-Lyonnet; H Bellaoui
Journal:  Neuromolecular Med       Date:  2013-01-16       Impact factor: 3.843

2.  Targeted Next-Generation Sequencing Revealed Novel Mutations in Chinese Ataxia Telangiectasia Patients: A Precision Medicine Perspective.

Authors:  Zhao Chen; Wei Ye; Zhe Long; Dongxue Ding; Huirong Peng; Xuan Hou; Rong Qiu; Kun Xia; Beisha Tang; Hong Jiang
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

3.  DNA methylation and gene expression signatures are associated with ataxia-telangiectasia phenotype.

Authors:  Sharon A McGrath-Morrow; Roland Ndeh; Kathryn A Helmin; Basil Khuder; Cynthia Rothblum-Oviatt; Joseph M Collaco; Jennifer Wright; Paul A Reyfman; Howard M Lederman; Benjamin D Singer
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

4.  Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network.

Authors:  Emilia Cirillo; Agata Polizzi; Luciana Chessa; Claudio Pignata; Annarosa Soresina; Rosaria Prencipe; Giuliana Giardino; Caterina Cancrini; Andrea Finocchi; Beatrice Rivalta; Rosa M Dellepiane; Lucia A Baselli; Davide Montin; Antonino Trizzino; Rita Consolini; Chiara Azzari; Silvia Ricci; Lorenzo Lodi; Isabella Quinti; Cinzia Milito; Lucia Leonardi; Marzia Duse; Maria Carrabba; Giovanna Fabio; Patrizia Bertolini; Paola Coccia; Irene D'Alba; Andrea Pession; Francesca Conti; Marco Zecca; Claudio Lunardi; Manuela Lo Bianco; Santiago Presti; Laura Sciuto; Roberto Micheli; Dario Bruzzese; Vassilios Lougaris; Raffaele Badolato; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2022-03-08       Impact factor: 8.542

Review 5.  Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders.

Authors:  Agata Pastorczak; Andishe Attarbaschi; Simon Bomken; Arndt Borkhardt; Jutte van der Werff Ten Bosch; Sarah Elitzur; Andrew R Gennery; Eva Hlavackova; Arpád Kerekes; Zdenka Křenová; Wojciech Mlynarski; Tomasz Szczepanski; Tessa Wassenberg; Jan Loeffen
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

6.  Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia.

Authors:  Tannaz Moeini Shad; Bahman Yousefi; Parisa Amirifar; Samaneh Delavari; William Rae; Parviz Kokhaei; Hassan Abolhassani; Asghar Aghamohammadi; Reza Yazdani
Journal:  J Clin Immunol       Date:  2020-10-14       Impact factor: 8.317

7.  Ataxia-Telangiectasia Presenting as Cerebral Palsy and Recurrent Wheezing: A Case Report.

Authors:  Marta Navratil; Vlasta Đuranović; Boro Nogalo; Alen Švigir; Iva Dumbović Dubravčić; Mirjana Turkalj
Journal:  Am J Case Rep       Date:  2015-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.